4.5 Article

PK11195 Effect on Steroidogenesis Is Not Mediated Through the Translocator Protein (TSPO)

Journal

ENDOCRINOLOGY
Volume 156, Issue 3, Pages 1033-1039

Publisher

ENDOCRINE SOC
DOI: 10.1210/en.2014-1707

Keywords

-

Funding

  1. Cornell College of Agriculture and Life Sciences
  2. National Institutes of Health [HD-17481]
  3. Robert A. Welch Foundation [B1-0028]
  4. Vietnam Education Foundation

Ask authors/readers for more resources

Translocator protein (TSPO) is a mitochondrial outer membrane protein of unknown function with high physiological expression in steroidogenic cells. Using TSPO gene-deleted mice, we recently demonstrated that TSPO function is not essential for steroidogenesis. The first link between TSPO and steroidogenesis was established in studies showing modest increases in progesterone production by adrenocortical and Leydig tumor cell lines after treatment with PK11195. To reconcile discrepancies between physiological and pharmacological interpretations of TSPO function, we generated TSPO-knockout MA-10 mouse Leydig tumor cells (MA-10: Tspo Delta/Delta) and examined their steroidogenic potential after exposure to either dibutyryl-cAMP or PK11195. Progesterone production in MA-10: Tspo Delta/Delta after dibutyryl-cAMP was not different from control MA-10: Tspo Delta/Delta cells, confirming that TSPO function is not essential for steroidogenesis. Interestingly, when treated with increasing concentrations of PK11195, both control MA-10: Tspo+/+ cells and MA-10: Tspo Delta/Delta cells responded in a similar dose-dependent manner showing increases in progesterone production. These results show that the pharmacological effect of PK11195 on steroidogenesis is not mediated through TSPO.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available